Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate
- 31 January 1987
- Vol. 29 (1) , 55-59
- https://doi.org/10.1016/0090-4295(87)90599-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Estramustine phosphate as primary therapy for metastatic prostate cancer: Preliminary results of the University of Wisconsin TrialUrology, 1984
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- Experience with Flutamide in Previously Untreated Patients With Advanced Prostatic CancerJournal of Urology, 1979
- Flutamide Therapy for Carcinoma of the ProstateSouthern Medical Journal, 1978
- Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancerUrology, 1976
- Advanced prostatic carcinoma Flutamide therapy after conventional endocrine treatmentUrology, 1975
- Physiologic Basis for Hormonal Therapy in Carcinoma of the ProstateUrologic Clinics of North America, 1975
- Sch 13521 In The Treatment Of Advanced Carcinoma Of The ProstateJournal of Urology, 1974
- On the Mechanism of the Anti-androgenic Action ofFlutamide (α-α-α-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide)in the RatEndocrinology, 1974
- A Biological Profile of a Nonsteroidal Antiandrogen, SCH 13521 (4'–Nitro–3'–Trifluoromethylisobutyranilide)1Endocrinology, 1972